{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:21:35Z","timestamp":1791606095979,"version":"4.3.4"},"reference-count":35,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.3892\/or.2015.3745","type":"journal-article","created":{"date-parts":[[2015,1,21]],"date-time":"2015-01-21T10:19:31Z","timestamp":1421835571000},"page":"1657-1666","source":"Crossref","is-referenced-by-count":17,"title":["Hepatic expression of the Sptlc3 subunit of serine palmitoyltransferase is associated with the development of hepatocellular carcinoma in a mouse model of nonalcoholic steatohepatitis"],"prefix":"10.3892","volume":"33","author":[{"given":"YOZO","family":"YOSHIMINE","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HIROFUMI","family":"UTO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KOTARO","family":"KUMAGAI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SEIICHI","family":"MAWATARI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SHIHO","family":"ARIMA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RIE","family":"IBUSUKI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KUMIKO","family":"MERA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TSUYOSHI","family":"NOSAKI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SHUJI","family":"KANMURA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MASATSUGU","family":"NUMATA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TSUTOMU","family":"TAMAI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AKIHIRO","family":"MORIUCHI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HIROHITO","family":"TSUBOUCHI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AKIO","family":"IDO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2015,1,21]]},"reference":[{"key":"key20180107212926_b1-or-33-04-1657","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0025-6196(24)00530-5","article-title":"Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease","volume":"55","author":"Ludwig","year":"1980","journal-title":"Mayo Clin Proc"},{"key":"key20180107212926_b2-or-33-04-1657","first-page":"11","article-title":"Nonalcoholic fatty liver disease","volume":"2","author":"Andy","year":"2002","journal-title":"Rev Gastrointest Disord"},{"key":"key20180107212926_b3-or-33-04-1657","doi-asserted-by":"crossref","first-page":"S186","DOI":"10.1046\/j.1440-1746.17.s1.10.x","article-title":"Non-alcoholic fatty liver disease Quadrennial review","volume":"17","author":"Angulo","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"key":"key20180107212926_b4-or-33-04-1657","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.cgh.2012.10.001","article-title":"Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review","volume":"10","author":"White","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key20180107212926_b5-or-33-04-1657","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1872-034X.2007.00119.x","article-title":"Report of the 17th Nationwide follow-up survey of primary liver cancer in Japan","volume":"37","author":"Ikai","year":"2007","journal-title":"Hepatol Res"},{"key":"key20180107212926_b6-or-33-04-1657","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","article-title":"Steatohepatitis: a tale of two \u2018hits\u2019?","volume":"114","author":"Day","year":"1998","journal-title":"Gastroenterology"},{"key":"key20180107212926_b7-or-33-04-1657","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonal-coholic fatty liver disease: the multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"key":"key20180107212926_b8-or-33-04-1657","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.0959-9673.2006.00465.x","article-title":"Mouse models in non-alcoholic fatty liver disease and steatohepatitis research","volume":"87","author":"Anstee","year":"2006","journal-title":"Int J Exp Pathol"},{"key":"key20180107212926_b9-or-33-04-1657","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1349-7006.2002.tb01250.x","article-title":"Development of hepatocellular adenomas and carcinomas associated with fibrosis in C57BL\/6J male mice given a choline-deficient, L-amino acid-defined diet","volume":"93","author":"Denda","year":"2002","journal-title":"Jpn J Cancer Res"},{"key":"key20180107212926_b10-or-33-04-1657","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00795-013-0016-1","article-title":"A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma","volume":"46","author":"Fujii","year":"2013","journal-title":"Med Mol Morphol"},{"key":"key20180107212926_b11-or-33-04-1657","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"key20180107212926_b12-or-33-04-1657","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1016\/S0140-6736(10)60706-4","article-title":"Linking diabetes and cancer: a consensus on complexity","volume":"375","author":"Renehan","year":"2010","journal-title":"Lancet"},{"key":"key20180107212926_b13-or-33-04-1657","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.clinre.2011.12.011","article-title":"HCC and NASH: how strong is the clinical demonstration?","volume":"36","author":"Rosmorduc","year":"2012","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"key20180107212926_b14-or-33-04-1657","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00281-012-0336-6","article-title":"Obesity and hepatocellular carcinoma: targeting obesity-related inflammation for chemo-prevention of liver carcinogenesis","volume":"35","author":"Shimizu","year":"2013","journal-title":"Semin Immunopathol"},{"key":"key20180107212926_b15-or-33-04-1657","doi-asserted-by":"crossref","first-page":"14635","DOI":"10.1074\/jbc.M608565200","article-title":"Glucose modulates basement membrane fibroblast growth factor-2 via alterations in endothelial cell permeability","volume":"282","author":"Morss","year":"2007","journal-title":"J Biol Chem"},{"key":"key20180107212926_b16-or-33-04-1657","first-page":"1384","article-title":"Quantitation of alpha-fetoprotein and albumin messenger RNA in human hepatocellular carcinoma","volume":"23","author":"Niwa","year":"1996","journal-title":"Hepatology"},{"key":"key20180107212926_b17-or-33-04-1657","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1499-3872(13)60028-4","article-title":"Values of circulating GPC-3 mRNA and alpha-fetoprotein in detecting patients with hepatocellular carcinoma","volume":"12","author":"Yao","year":"2013","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"key20180107212926_b18-or-33-04-1657","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/ijc.20979","article-title":"Enzymatic detection of precursor cell populations of preneoplastic foci positive for gamma-glutamyltranspeptidase in rat liver","volume":"115","author":"Satoh","year":"2005","journal-title":"Int J Cancer"},{"key":"key20180107212926_b19-or-33-04-1657","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s00534-010-0367-0","article-title":"The clinicopathological significance of heat shock protein 70 and glutamine synthetase expression in hepatocellular carcinoma","volume":"18","author":"Shin","year":"2011","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"key20180107212926_b20-or-33-04-1657","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/hep.22734","article-title":"Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis","volume":"49","author":"Paradis","year":"2009","journal-title":"Hepatology"},{"key":"key20180107212926_b21-or-33-04-1657","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/ni.2022","article-title":"Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling","volume":"12","author":"Wen","year":"2011","journal-title":"Nat Immunol"},{"key":"key20180107212926_b22-or-33-04-1657","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S1388-1981(03)00059-3","article-title":"Serine palmitoyltransferase, a key enzyme of sphingolipid metabolism","volume":"1632","author":"Hanada","year":"2003","journal-title":"Biochim Biophys Acta"},{"key":"key20180107212926_b23-or-33-04-1657","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S1043-6618(03)00054-9","article-title":"Sphingoid bases and de novo ceramide synthesis: enzymes involved, pharmacology and mechanisms of action","volume":"47","author":"Menaldino","year":"2003","journal-title":"Pharmacol Res"},{"key":"key20180107212926_b24-or-33-04-1657","doi-asserted-by":"crossref","first-page":"37275","DOI":"10.1074\/jbc.M608066200","article-title":"Cloning and initial characterization of a new subunit for mammalian serine-palmitoyltransferase","volume":"281","author":"Hornemann","year":"2006","journal-title":"J Biol Chem"},{"key":"key20180107212926_b25-or-33-04-1657","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1042\/BJ20070025","article-title":"Is the mammalian serine palmitoyltransferase a high-molecular-mass complex?","volume":"405","author":"Hornemann","year":"2007","journal-title":"Biochem J"},{"key":"key20180107212926_b26-or-33-04-1657","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/hep.26606","article-title":"Hepatic cannabinoid-1 receptors mediate diet-induced insulin resistance by increasing de novo synthesis of long-chain ceramides","volume":"59","author":"Cinar","year":"2014","journal-title":"Hepatology"},{"key":"key20180107212926_b27-or-33-04-1657","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.2337\/db09-1293","article-title":"Inhibition of de novo ceramide synthesis reverses diet-induced insulin resistance and enhances whole-body oxygen consumption","volume":"59","author":"Ussher","year":"2010","journal-title":"Diabetes"},{"key":"key20180107212926_b28-or-33-04-1657","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3233\/JAD-2009-0984","article-title":"Hepatic ceramide may mediate brain insulin resistance and neurodegeneration in type 2 diabetes and non-alcoholic steatohepatitis","volume":"16","author":"Lyn-Cook","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"key20180107212926_b29-or-33-04-1657","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1872-034X.2011.00815.x","article-title":"Weight loss amelioration of non-alcoholic steatohepatitis linked to shifts in hepatic ceramide expression and serum ceramide levels","volume":"41","author":"Promrat","year":"2011","journal-title":"Hepatol Res"},{"key":"key20180107212926_b30-or-33-04-1657","doi-asserted-by":"crossref","first-page":"980815","DOI":"10.1155\/2014\/980815","article-title":"Inhibition of ceramide de novo synthesis with myriocin affects lipid metabolism in the liver of rats with streptozotocin-induced type 1 diabetes","volume":"2014","author":"Kurek","year":"2014","journal-title":"Biomed Res Int"},{"key":"key20180107212926_b31-or-33-04-1657","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1365-2184.2011.00761.x","article-title":"Serine palmitoyltransferase inhibitor myriocin induces growth inhibition of B16F10 melanoma cells through G(2)\/M phase arrest","volume":"44","author":"Lee","year":"2011","journal-title":"Cell Prolif"},{"key":"key20180107212926_b32-or-33-04-1657","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4161\/cbt.13.2.18870","article-title":"Myriocin, a serine palmitoyltransferase inhibitor, suppresses tumor growth in a murine melanoma model by inhibiting de novo sphingolipid synthesis","volume":"13","author":"Lee","year":"2012","journal-title":"Cancer Biol Ther"},{"key":"key20180107212926_b33-or-33-04-1657","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/dmrr.291","article-title":"Insulin resistance in type 1 diabetes","volume":"18","author":"Greenbaum","year":"2002","journal-title":"Diab Metab Res Rev"},{"key":"key20180107212926_b34-or-33-04-1657","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1007\/s10620-011-1807-7","article-title":"Nonalcoholic fatty liver disease markers are associated with insulin resistance in type 1 diabetes","volume":"56","author":"Bulum","year":"2011","journal-title":"Dig Dis Sci"},{"key":"key20180107212926_b35-or-33-04-1657","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1900\/RDS.2011.8.454","article-title":"Hepatic steatosis in type 1 diabetes","volume":"8","author":"Regnell","year":"2011","journal-title":"Rev Diab Stud"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2015.3745\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T08:58:51Z","timestamp":1747472331000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2015.3745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,21]]},"references-count":35,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,1,21]]},"published-print":{"date-parts":[[2015,4]]}},"alternative-id":["10.3892\/or.2015.3745"],"URL":"https:\/\/doi.org\/10.3892\/or.2015.3745","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,21]]}}}